XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma (clinicaltrials.gov) - Apr 1, 2021 - P2; N=70; Recruiting; Sponsor: Chemlmmune Therapeutics LLC; Not yet recruiting ➔ Recruiting
Enrollment open • Asthma • Immunology • Respiratory Diseases
|